Literature DB >> 26227792

Association Between Paraoxonase Gene Polymorphisms and Intracerebral Hemorrhage in a Korean Population.

Hae Jeong Park1,2, Su Kang Kim1, Hyun-Kyung Park1, Joo-Ho Chung3.   

Abstract

The human paraoxonase (PON) gene family includes three members: PON1, PON2, and PON3. PON, which prevents the oxidative modification of lipoproteins, has been implicated as a potential risk factor of the cerebrovascular disease. In this study, we investigated associations between coding region single-nucleotide polymorphisms (cSNPs) of PON1, PON2, and PON3 genes and intracerebral hemorrhage (ICH) in a Korean population. Six cSNPs [rs13306698 and rs662 for PON1; rs12026 and rs7493 for PON2; rs13226149 and rs1053275 for PON3] were genotyped using direct sequencing in 145 ICH patients and 372 control subjects. Of the six cSNPs, rs12026 and rs7493, which were in complete linkage disequilibrium, were associated with ICH in log-additive (GC vs. CC vs. GG, p = 0.0008, OR = 0.53, 95 % CI = 0.36-0.78) and dominant models (GC/CC vs. GG, p = 0.0006, OR = 0.47, 95 % CI = 0.30-0.73). In addition, rs13226149 was associated with ICH in log-additive model (GA vs. AA vs. GG, p = 0.0033, OR = 0.58, 95 % CI = 0.39-0.84). In the allele frequency analysis, the C alleles of rs12026 and rs7493 and the A allele of rs13226149 were also shown to contribute to the decreased risk of ICH (p = 0.001, OR = 0.55, 95 % CI = 0.38-0.80 in rs12026 and rs7493; p = 0.003, OR = 0.58, 95 % CI = 0.40-0.83 in rs13226149). These results suggest that PON genes may be involved in the susceptibility of ICH.

Entities:  

Keywords:  Intracerebral hemorrhage; Paraoxonase; Polymorphism

Mesh:

Substances:

Year:  2015        PMID: 26227792     DOI: 10.1007/s12031-015-0620-8

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  35 in total

1.  PON2 gene variants are associated with clinical manifestations of cardiovascular disease in familial hypercholesterolemia patients.

Authors:  F R Leus; M Zwart; J J Kastelein; H A Voorbij
Journal:  Atherosclerosis       Date:  2001-02-15       Impact factor: 5.162

2.  Paraoxonase 2 gene C311S polymorphism is associated with a risk of large vessel disease stroke in a Polish population.

Authors:  Agnieszka Slowik; Dorota Wloch; Pawel Szermer; Pawel Wolkow; Maciej Malecki; Joanna Pera; Wojciech Turaj; Tomasz Dziedzic; Aleksandra Klimkowicz-Mrowiec; Grzegorz Kopec; Denise A Figlewicz; Andrzej Szczudlik
Journal:  Cerebrovasc Dis       Date:  2007-04-02       Impact factor: 2.762

3.  Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase.

Authors:  M Aviram; M Rosenblat; C L Bisgaier; R S Newton; S L Primo-Parmo; B N La Du
Journal:  J Clin Invest       Date:  1998-04-15       Impact factor: 14.808

4.  The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family.

Authors:  S L Primo-Parmo; R C Sorenson; J Teiber; B N La Du
Journal:  Genomics       Date:  1996-05-01       Impact factor: 5.736

5.  Evaluation of the paraoxonases as candidate genes for stroke: Gln192Arg polymorphism in the paraoxonase 1 gene is associated with increased risk of stroke.

Authors:  Koustubh Ranade; Todd G Kirchgessner; Olga A Iakoubova; James J Devlin; Terrye DelMonte; Priya Vishnupad; Lester Hui; Zenta Tsuchihashi; Frank M Sacks; Marc S Sabatine; Eugene Braunwald; Thomas J White; Peter M Shaw; Nicholas C Dracopoli
Journal:  Stroke       Date:  2005-10-20       Impact factor: 7.914

6.  Associations of serum total cholesterol, different types of stroke, and stenosis distribution of cerebral arteries. The Akita Pathology Study.

Authors:  M Konishi; H Iso; Y Komachi; M Iida; T Shimamoto; D R Jacobs; A Terao; S Baba; T Sankai; M Ito
Journal:  Stroke       Date:  1993-07       Impact factor: 7.914

7.  Human growth hormone-releasing hormone analogues with much improved in vitro growth hormone-releasing potencies in rat pituitary cells.

Authors:  D H Coy; S J Hocart; W A Murphy
Journal:  Eur J Pharmacol       Date:  1991-11-05       Impact factor: 4.432

8.  Synergistic effects between Q192R polymorphism of paraoxonase 1 gene and some conventional risk factors in premature coronary artery disease.

Authors:  Anna Balcerzyk; Iwona Zak; Jolanta Krauze
Journal:  Arch Med Res       Date:  2007-07       Impact factor: 2.235

9.  Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase.

Authors:  M I Mackness; S Arrol; C Abbott; P N Durrington
Journal:  Atherosclerosis       Date:  1993-12       Impact factor: 5.162

10.  Oxidative stress in white coat hypertension; role of paraoxonase.

Authors:  H Uzun; Y Karter; S Aydin; A Curgunlu; G Simşek; R Yücel; S Vehiyd; N Ertürk; A Kutlu; A Benian; A Yaldiran; E Oztürk; S Erdine
Journal:  J Hum Hypertens       Date:  2004-07       Impact factor: 3.012

View more
  1 in total

1.  Genetic susceptibility to cerebrovascular disease: A systematic review.

Authors:  Christoph J Griessenauer; Sean Farrell; Atom Sarkar; Ramin Zand; Vida Abedi; Neil Holland; Andrew Michael; Christopher L Cummings; Raghu Metpally; David J Carey; Oded Goren; Neil Martin; Philipp Hendrix; Clemens M Schirmer
Journal:  J Cereb Blood Flow Metab       Date:  2018-09-05       Impact factor: 6.200

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.